These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 170856)

  • 41. Comparative activity of mecillinam and ampicillin singly and in combination in the urinary bladder model and experimental mouse model.
    Anderson JD; Eftekhar F; Cleeland R; Kramer MJ; Beskid G
    J Antimicrob Chemother; 1981 Aug; 8(2):121-31. PubMed ID: 6268599
    [No Abstract]   [Full Text] [Related]  

  • 42. [Comparison of antibacterial activity of mecillinam against recently isolated bacilli of 5 genera of Enterobacteriaceae from clinical materials with ampicillin, amoxicillin, cephalexin, nalidixic acid and pipemidic acid (author's transl)].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1979 Aug; 32(8):812-8. PubMed ID: 226736
    [No Abstract]   [Full Text] [Related]  

  • 43. Mecillinam.
    Bakhtiar M; Selwyn S
    Lancet; 1978 Feb; 1(8059):337. PubMed ID: 75379
    [No Abstract]   [Full Text] [Related]  

  • 44. In vitro bactericidal activity of sulbactam plus ampicillin against methicillin-resistant Staphylococcus aureus.
    Kazmierczak A; Duez JM; Pechinot A; Nordmann P; Labia R
    Rev Infect Dis; 1986; 8 Suppl 5():S549-54. PubMed ID: 3026003
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In-vitro susceptibility of beta-lactamase-producing Haemophilus influenzae to the combinations ampicillin with mecillinam and ampicillin and VD2085.
    Piot P; van Dyck E
    J Antimicrob Chemother; 1985 Dec; 16(6):808-9. PubMed ID: 3005221
    [No Abstract]   [Full Text] [Related]  

  • 46. Inhibition of lateral wall elongation by mecillinam stimulates cell division in certain cell division conditional mutants of Escherichia coli.
    Canepari P; Botta G; Satta G
    J Bacteriol; 1984 Jan; 157(1):130-3. PubMed ID: 6317646
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the epidemiology of bacterial resistance to mecillinam and ampicillin.
    Anderson JD; Adams MA; Barrington JC; Spence WN; Sheperd CA
    Antimicrob Agents Chemother; 1976 Dec; 10(6):872-7. PubMed ID: 1051328
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Growth properties of mecillinam-resistant bacterial variants in urine.
    Anderson JD; Adams MA; Webster HM; Smith L
    Antimicrob Agents Chemother; 1977 Nov; 12(5):559-62. PubMed ID: 200171
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Susceptibility to mecillinam and other antibiotics and serogroups of enterotoxigenic Escherichia coli from children in Addis Ababa.
    Stintzing G; Jacobsen J
    J Antimicrob Chemother; 1983 Nov; 12(5):469-74. PubMed ID: 6323370
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of beta-lactamase and the outer-membrane structure in the resistance of Enterobacteriaceae to mecillinam.
    Bongaerts GP; Bruggeman-Ogle K
    Antonie Van Leeuwenhoek; 1980; 46(1):99. PubMed ID: 6249199
    [No Abstract]   [Full Text] [Related]  

  • 51. In vitro interaction between mecillinam and piperacillin-tazobactam in the presence of azithromycin against members of the Enterobacteriaceae family and Pseudomonas aeruginosa.
    Maioli E; Debbia EA; Gualco L; Marchese A
    New Microbiol; 2008 Jan; 31(1):37-46. PubMed ID: 18437840
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Morphologic changes produced by amdinocillin alone and in combination with beta-lactam antibiotics: in vitro and in vivo.
    Kramer MJ; Mauriz YR; Timmes MD; Robertson TL; Cleeland R
    Am J Med; 1983 Aug; 75(2A):30-41. PubMed ID: 6311003
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microbiological evaluation of 6-beta-amidino-penicillanic acid (mecillinam).
    Speciale A; Blandino G; Foresta P; Toscano MA
    Antibiotica; 1975; 13(2-3):80-99. PubMed ID: 193435
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of osmolality on the response of Escherichia coli to mecillinam.
    Greenwood D
    Antimicrob Agents Chemother; 1976 Nov; 10(5):824-6. PubMed ID: 795371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mapping of the mecillinam-resistant, round morphological mutants of Escherichia coli.
    Iwaya M; Jones CW; Khorana J; Strominger JL
    J Bacteriol; 1978 Jan; 133(1):196-202. PubMed ID: 201607
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Comparison of in vitro activity of ciclacillin and other penicilline(author's transl)].
    Baier R; Puppel H
    Med Klin; 1975 Jan; 70(1):24-6. PubMed ID: 164612
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of the bactericidal activities of piperacillin-tazobactam, ticarcillin-clavulanate, and ampicillin-sulbactam against clinical isolates of Bacteroides fragilis, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa.
    Klepser ME; Marangos MN; Zhu Z; Nicolau DP; Quintiliani R; Nightingale CH
    Antimicrob Agents Chemother; 1997 Feb; 41(2):435-9. PubMed ID: 9021203
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro activity of mecillinam against anaerobic bacteria.
    Steinkraus GE; McCarthy LR
    Antimicrob Agents Chemother; 1980 Jun; 17(6):954-6. PubMed ID: 6250471
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibiotic sensitivity of enteropathogenic Escherichia coli to mecillinam, trimethoprim-sulfamethoxazole and other antibiotics.
    Thorén A
    Acta Pathol Microbiol Scand B; 1980 Oct; 88(5):265-8. PubMed ID: 6258383
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro activity of moxalactam and mecillinam, singly and in combination, against multi-drug-resistant Enterobacteriaceae and Pseudomonas species.
    Fass RJ
    Antimicrob Agents Chemother; 1982 Jan; 21(1):188-91. PubMed ID: 6282206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.